{"id":124467,"date":"2025-06-24T13:45:56","date_gmt":"2025-06-24T06:45:56","guid":{"rendered":"https:\/\/hmm88i.com\/drug\/?post_type=product&p=124467"},"modified":"2025-07-24T11:48:01","modified_gmt":"2025-07-24T04:48:01","slug":"mvasi-100mg-4ml","status":"publish","type":"product","link":"https:\/\/hmm88i.com\/drug\/mvasi-100mg-4ml\/","title":{"rendered":"Mvasi 100mg\/4ml"},"content":{"rendered":"

Trong b\u00e0i vi\u1ebft n\u00e0y, d\u01b0\u1ee3c s\u0129 L\u01b0u V\u0103n Ho\u00e0ng gi\u1edbi thi\u1ec7u \u0111\u1ebfn c\u00e1c b\u1ea1n thu\u1ed1c Mvasi 100mg\/4ml \u0111\u01b0\u1ee3c s\u1ea3n xu\u1ea5t b\u1edfi Patheon Manufacturing Services LLC c\u00f3 s\u1ed1 \u0111\u0103ng k\u00fd l\u01b0u h\u00e0nh t\u1ea1i Vi\u1ec7t Nam l\u00e0 001410179600 (S\u0110K c\u0169: SP3-1221-21)<\/strong><\/p>\n

Mvasi 100mg\/4ml l\u00e0 thu\u1ed1c g\u00ec?<\/h2>\n

Th\u00e0nh ph\u1ea7n<\/h3>\n

Trong m\u1ed7i 4ml dung d\u1ecbch Mvasi 100mg\/4ml<\/strong> c\u00f3 ch\u1ee9a:<\/p>\n

Bevacizumab\u2026\u2026\u2026\u2026.100mg<\/p>\n

D\u1ea1ng b\u00e0o ch\u1ebf: Dung d\u1ecbch \u0111\u1eadm \u0111\u1eb7c pha truy\u1ec1n<\/p>\n

Tr\u00ecnh b\u00e0y<\/h3>\n

S\u0110K: 001410179600 (S\u0110K c\u0169: SP3-1221-21)<\/p>\n

Quy c\u00e1ch \u0111\u00f3ng g\u00f3i: H\u1ed9p 1 l\u1ecd x 4ml<\/p>\n

Xu\u1ea5t x\u1ee9: Hoa K\u1ef3<\/p>\n

H\u1ea1n s\u1eed d\u1ee5ng: 36 th\u00e1ng<\/p>\n

T\u00e1c d\u1ee5ng c\u1ee7a thu\u1ed1c Mvasi 100mg\/4ml<\/h2>\n

C\u01a1 ch\u1ebf t\u00e1c d\u1ee5ng<\/h3>\n

Mvasi (bevacizumab) l\u00e0 m\u1ed9t kh\u00e1ng th\u1ec3 \u0111\u01a1n d\u00f2ng t\u00e1i t\u1ed5 h\u1ee3p nh\u1eafm \u0111\u00edch y\u1ebfu t\u1ed1 t\u0103ng tr\u01b0\u1edfng n\u1ed9i m\u00f4 m\u1ea1ch m\u00e1u (VEGF) \u2013 m\u1ed9t ph\u00e2n t\u1eed then ch\u1ed1t trong qu\u00e1 tr\u00ecnh h\u00ecnh th\u00e0nh m\u1ea1ch m\u00e1u m\u1edbi. B\u1eb1ng c\u00e1ch g\u1eafn v\u00e0o VEGF, bevacizumab ng\u0103n ch\u1eb7n VEGF t\u01b0\u01a1ng t\u00e1c v\u1edbi c\u00e1c th\u1ee5 th\u1ec3 VEGFR-1 (Flt-1) v\u00e0 VEGFR-2 (KDR) tr\u00ean t\u1ebf b\u00e0o n\u1ed9i m\u00f4, t\u1eeb \u0111\u00f3 \u1ee9c ch\u1ebf qu\u00e1 tr\u00ecnh t\u00e2n m\u1ea1ch \u2013 v\u1ed1n \u0111\u00f3ng vai tr\u00f2 cung c\u1ea5p dinh d\u01b0\u1ee1ng v\u00e0 oxy cho s\u1ef1 ph\u00e1t tri\u1ec3n c\u1ee7a kh\u1ed1i u.<\/p>\n

T\u00e1c \u0111\u1ed9ng sinh h\u1ecdc c\u1ee7a thu\u1ed1c kh\u00f4ng ch\u1ec9 ng\u0103n ch\u1eb7n s\u1ef1 t\u1ea1o m\u1ea1ch m\u1edbi m\u00e0 c\u00f2n l\u00e0m gi\u1ea3m t\u00ednh th\u1ea5m c\u1ee7a m\u1ea1ch m\u00e1u v\u00e0 c\u1ea3i thi\u1ec7n s\u1ef1 ph\u00e2n ph\u1ed1i thu\u1ed1c trong m\u00f4 ung th\u01b0.<\/p>\n

\u0110\u1eb7c \u0111i\u1ec3m d\u01b0\u1ee3c \u0111\u1ed9ng h\u1ecdc<\/h3>\n
    \n
  • Ph\u00e2n b\u1ed1: Th\u1ec3 t\u00edch ph\u00e2n b\u1ed1 trung t\u00e2m kho\u1ea3ng 2,73\u20133,28 L v\u00e0 ngo\u1ea1i bi\u00ean kho\u1ea3ng 1,69\u20132,35 L, cho th\u1ea5y thu\u1ed1c ph\u00e2n b\u1ed1 ch\u1ee7 y\u1ebfu trong d\u1ecbch ngo\u1ea1i b\u00e0o. Nam gi\u1edbi c\u00f3 khuynh h\u01b0\u1edbng ph\u00e2n b\u1ed1 thu\u1ed1c r\u1ed9ng h\u01a1n so v\u1edbi n\u1eef sau khi \u0111i\u1ec1u ch\u1ec9nh theo tr\u1ecdng l\u01b0\u1ee3ng c\u01a1 th\u1ec3.<\/li>\n
  • Chuy\u1ec3n h\u00f3a: Gi\u1ed1ng c\u00e1c globulin mi\u1ec5n d\u1ecbch IgG, bevacizumab b\u1ecb ph\u00e2n h\u1ee7y th\u00f4ng qua h\u1ec7 th\u1ed1ng t\u1ebf b\u00e0o ti\u00eau h\u00f3a protein trong to\u00e0n c\u01a1 th\u1ec3. Kh\u00f4ng ph\u1ee5 thu\u1ed9c v\u00e0o th\u1ea3i tr\u1eeb qua gan ho\u1eb7c th\u1eadn.<\/li>\n
  • Th\u1ea3i tr\u1eeb: Thu\u1ed1c c\u00f3 th\u1eddi gian b\u00e1n th\u1ea3i trung b\u00ecnh kho\u1ea3ng 18\u201320 ng\u00e0y. T\u1ed1c \u0111\u1ed9 thanh th\u1ea3i cao h\u01a1n \u1edf b\u1ec7nh nh\u00e2n c\u00f3 albumin huy\u1ebft th\u1ea5p ho\u1eb7c kh\u1ed1i l\u01b0\u1ee3ng kh\u1ed1i u l\u1edbn.<\/li>\n<\/ul>\n

    Thu\u1ed1c Mvasi 100mg\/4ml \u0111\u01b0\u1ee3c ch\u1ec9 \u0111\u1ecbnh trong b\u1ec7nh g\u00ec?<\/h2>\n
      \n
    • Ung th\u01b0 \u0111\u1ea1i tr\u1ef1c tr\u00e0ng di c\u0103n: Ph\u1ed1i h\u1ee3p v\u1edbi fluoropyrimidine trong \u0111i\u1ec1u tr\u1ecb b\u1ec7nh ti\u1ebfn tri\u1ec3n.<\/li>\n
    • Ung th\u01b0 v\u00fa di c\u0103n: K\u1ebft h\u1ee3p paclitaxel trong b\u01b0\u1edbc \u0111i\u1ec1u tr\u1ecb \u0111\u1ea7u ti\u00ean.<\/li>\n
    • Ung th\u01b0 ph\u1ed5i kh\u00f4ng t\u1ebf b\u00e0o nh\u1ecf (NSCLC):<\/li>\n<\/ul>\n
        \n
      1. Ph\u1ed1i h\u1ee3p h\u00f3a tr\u1ecb b\u1ea1ch kim cho b\u1ec7nh nh\u00e2n kh\u00f4ng ph\u1ea3i m\u00f4 h\u1ecdc t\u1ebf b\u00e0o v\u1ea3y.<\/li>\n
      2. Ph\u1ed1i h\u1ee3p v\u1edbi erlotinib n\u1ebfu c\u00f3 \u0111\u1ed9t bi\u1ebfn ho\u1ea1t h\u00f3a EGFR.<\/li>\n<\/ol>\n
          \n
        • Ung th\u01b0 t\u1ebf b\u00e0o th\u1eadn: S\u1eed d\u1ee5ng v\u1edbi interferon alfa-2a trong giai \u0111o\u1ea1n ti\u1ebfn tri\u1ec3n ho\u1eb7c di c\u0103n.<\/li>\n
        • Ung th\u01b0 bu\u1ed3ng tr\u1ee9ng, \u1ed1ng d\u1eabn tr\u1ee9ng, m\u00e0ng b\u1ee5ng nguy\u00ean ph\u00e1t:<\/li>\n<\/ul>\n
            \n
          1. Giai \u0111o\u1ea1n ti\u1ebfn tri\u1ec3n: ph\u1ed1i h\u1ee3p carboplatin\/paclitaxel.<\/li>\n
          2. T\u00e1i ph\u00e1t nh\u1ea1y c\u1ea3m v\u1edbi b\u1ea1ch kim: ph\u1ed1i h\u1ee3p carboplatin-gemcitabine ho\u1eb7c carboplatin-paclitaxel.<\/li>\n
          3. T\u00e1i ph\u00e1t kh\u00e1ng b\u1ea1ch kim: ph\u1ed1i h\u1ee3p paclitaxel, topotecan ho\u1eb7c doxorubicin liposome.<\/li>\n<\/ol>\n
              \n
            • Ung th\u01b0 c\u1ed5 t\u1eed cung: Ph\u1ed1i h\u1ee3p paclitaxel v\u1edbi cisplatin ho\u1eb7c topotecan.<\/li>\n<\/ul>\n
              \"Mvasi
              Mvasi 400mg\/16ml<\/figcaption><\/figure>\n

              Li\u1ec1u d\u00f9ng v\u00e0 c\u00e1ch s\u1eed d\u1ee5ng<\/h2>\n

              Li\u1ec1u d\u00f9ng<\/h3>\n\n\n\n\n\n\n\n\n\n\n\n\n\n
              Ch\u1ec9 \u0111\u1ecbnh<\/strong><\/th>\nLi\u1ec1u d\u00f9ng khuy\u1ebfn ngh\u1ecb<\/strong><\/th>\n<\/tr>\n<\/thead>\n
              Ung th\u01b0 \u0111\u1ea1i tr\u1ef1c\/\u0111\u1ea1i tr\u00e0ng di c\u0103n (mCRC)<\/td>\n5\u201310 mg\/kg 2 tu\u1ea7n\/l\u1ea7n ho\u1eb7c 7,5\u201315 mg\/kg 3 tu\u1ea7n\/l\u1ea7n<\/td>\n<\/tr>\n
              Ung th\u01b0 v\u00fa di c\u0103n (mBC)<\/td>\n10 mg\/kg 2 tu\u1ea7n\/l\u1ea7n ho\u1eb7c 15 mg\/kg 3 tu\u1ea7n\/l\u1ea7n<\/td>\n<\/tr>\n
              NSCLC (b\u1ea1ch kim)<\/td>\n7,5 ho\u1eb7c 15 mg\/kg 3 tu\u1ea7n\/l\u1ea7n (t\u1ed1i \u0111a 6 chu k\u1ef3, sau \u0111\u00f3 \u0111\u01a1n tr\u1ecb \u0111\u1ebfn khi b\u1ec7nh ti\u1ebfn tri\u1ec3n)<\/td>\n<\/tr>\n
              NSCLC (EGFR+)<\/td>\n15 mg\/kg 3 tu\u1ea7n\/l\u1ea7n, ph\u1ed1i h\u1ee3p erlotinib<\/td>\n<\/tr>\n
              Ung th\u01b0 t\u1ebf b\u00e0o th\u1eadn ti\u1ebfn tri\u1ec3n\/di c\u0103n (mRCC)<\/td>\n10 mg\/kg 2 tu\u1ea7n\/l\u1ea7n<\/td>\n<\/tr>\n
              Ung th\u01b0 bu\u1ed3ng tr\u1ee9ng (giai \u0111o\u1ea1n ti\u1ebfn tri\u1ec3n)<\/td>\n15 mg\/kg 3 tu\u1ea7n\/l\u1ea7n, t\u1ed1i \u0111a 15 th\u00e1ng<\/td>\n<\/tr>\n
              T\u00e1i ph\u00e1t nh\u1ea1y c\u1ea3m b\u1ea1ch kim<\/td>\n15 mg\/kg 3 tu\u1ea7n\/l\u1ea7n<\/td>\n<\/tr>\n
              T\u00e1i ph\u00e1t kh\u00e1ng b\u1ea1ch kim<\/td>\n10 mg\/kg 2 tu\u1ea7n\/l\u1ea7n ho\u1eb7c 15 mg\/kg 3 tu\u1ea7n\/l\u1ea7n (topotecan)<\/td>\n<\/tr>\n
              Ung th\u01b0 c\u1ed5 t\u1eed cung<\/td>\n15 mg\/kg 3 tu\u1ea7n\/l\u1ea7n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

              C\u00e1ch s\u1eed d\u1ee5ng<\/h3>\n